Sundaram Multi Pap Limited has informed the Exchange regarding 'Clarification on Outcome of Board Meeting held on February 14, 2026'.
SUNDARAM · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Sundaram Multi Pap filed a clarification with NSE confirming that the unaudited standalone financial results for Q3 FY26 and nine months ended December 31, 2025, originally approved on February 14, 2026, contain no changes. Q3 revenue from operations grew about 22% year-on-year to Rs 2,606.83 lakhs from Rs 2,135.53 lakhs. The company swung from a net loss of Rs 268.53 lakhs in Q3 FY25 to a net profit of Rs 161.99 lakhs in Q3 FY26. For the nine-month period, net profit was Rs 200.62 lakhs versus a loss of Rs 426.81 lakhs last year. The auditor (Ashok Shyam and Associates) issued an unmodified limited review report, and an exceptional item of Rs 17.07 lakhs (interest income under Ind AS 116) was recorded in the quarter.
This is a clear turnaround quarter — revenue growth of 22% combined with a return to profitability after a full-year FY25 loss of Rs 512 lakhs is a positive signal for shareholders. However, margins remain thin (Q3 PAT margin around 6%) and the nine-month profit of Rs 200 lakhs is still small relative to the Rs 4,739 lakh equity base, so sustained improvement will be needed to drive meaningful stock movement.